SCHEMBL7328495

SCHEMBL7328495

CC(C)(C)OC(=O)NNCCc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSK P43235 3/20 0.50
CA12 O43570 1/20 0.50
CA1 P00915 1/20 0.50
CA7 P43166 1/20 0.50
CA14 Q9ULX7 1/20 0.50
NPC1 O15118 3/20 0.49
RAB9A P51151 3/20 0.49
MAPT P10636 1/20 0.49
CTSS P25774 1/20 0.48
IDO1 P14902 1/20 0.48
AKT1 P31749 2/20 0.48
MEN1 O00255 1/20 0.47
GAA P10253 1/20 0.47
KMT2A Q03164 1/20 0.47
SIGMAR1 Q99720 3/20 0.46
HDAC3 O15379 2/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC2 Q92769 1/20 0.46
NCOR2 Q9Y618 1/20 0.46
SYK P43405 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7965253 0.91 HDAC3 (0.55) CTSKCA12CA1CA7CA14
SCHEMBL30754110 0.86 NPC1 (0.47) CTSKCA1NPC1RAB9ACTSS
SCHEMBL20581863 0.85 HPGD (0.46) CTSKCA1NPC1RAB9ACTSS
SCHEMBL572740 0.84 IDO1 (0.60) CTSKCA12CA1CA7CA14
SCHEMBL4632779 0.84 CA12 (0.60) CTSKCA12CA1CA7CA14
SCHEMBL4079236 0.82 CYP4A11 (0.50) CA12CA1CA7CA14NPC1
SCHEMBL644883 0.81 SYK (0.50) CA12CA1CA7CA14MAPT
SCHEMBL27190527 0.81 SMN1; SMN2 (0.57) CA12CA1CA7CA14MAPT
SCHEMBL27526855 0.81 L3MBTL1 (0.53) CA12CA1CA7CA14NPC1
SCHEMBL6874531 0.81 NQO2 (0.46) CTSKCA12CA1CA7CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5990135-A FOR TREATING A RETROVIRAL INFECTION SUCH AS HIV INFECTION; FOR EXAMPLE 5S-N-((2-PYRIDINYL)METHOXYCARBONYL)VALINYLAMINO-2-((N-3 -PYRIDINYL)METHOXYCARBONYL)AMINO-4S-HYDROXY-1,6-DIPHENYL-2-AZAHEXANE AND OTHER COMPOUNDS OF GIVEN FORMULA ABBOTT LABORATORIES (US) 1999-11-23 US disclosed
US-5631376-A PEPTIDE DERIVATIVES FOR TREATMENT OF AIDS ABBOTT LABORATORIES (US) 1997-05-20 US disclosed
US-5621109-A OXAZOLE/THIAZOLE DERIVATIVES OF HYDROXYMETHYL HYDRAZONES; SIDE EFFECT REDUCTION ABBOTT LABORATORIES (US) 1997-04-15 US disclosed
US-5461067-A For HIV infections ABBOTT LABORATORIES (US) 1995-10-24 US disclosed
EP-0631571-A1 PREPARATION OF OPTICALLY ACTIVE HYDRAZINES AND AMINES. DU PONT (US) 1995-01-04 EP disclosed
WO-1994019332-A1 RETROVIRAL PROTEASE INHIBITING COMPOUNDS ABBOTT LABORATORIES (US) 1994-09-01 WO disclosed
US-5280027-A Quinazoline containing compound IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1994-01-18 US disclosed
US-5202312-A Antiarthritic agents, antiallergens, antidiabetic agents TANABE SEIYAKU CO., LTD. (JP) 1993-04-13 US disclosed
EP-0459730-A2 Anti-tumour compounds ZENECA LIMITED (GB) 1991-12-04 EP disclosed